Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Theranostics and metabolotheranostics for precision medicine in oncology.

Bhujwalla ZM, Kakkad S, Chen Z, Jin J, Hapuarachchige S, Artemov D, Penet MF.

J Magn Reson. 2018 Jun;291:141-151. doi: 10.1016/j.jmr.2018.03.004. Epub 2018 Apr 26.

PMID:
29705040
2.

Direct Cell Labeling to Image Transplanted Stem Cells in Real Time Using a Dual-Contrast MRI Technique.

Ngen EJ, Kato Y, Artemov D.

Curr Protoc Stem Cell Biol. 2017 Aug 14;42:5A.10.1-5A.10.19. doi: 10.1002/cpsc.33.

PMID:
28806856
3.

Advances in Monitoring Cell-Based Therapies with Magnetic Resonance Imaging: Future Perspectives.

Ngen EJ, Artemov D.

Int J Mol Sci. 2017 Jan 19;18(1). pii: E198. doi: 10.3390/ijms18010198. Review.

4.

Click Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging.

Hapuarachchige S, Artemov D.

Top Magn Reson Imaging. 2016 Oct;25(5):205-213. Review.

5.

Invasive Breast Cancer Preferably and Predominantly Occurs at the Interface Between Fibroglandular and Adipose Tissue.

Zhu W, Harvey S, Macura KJ, Euhus DM, Artemov D.

Clin Breast Cancer. 2017 Feb;17(1):e11-e18. doi: 10.1016/j.clbc.2016.07.009. Epub 2016 Jul 28.

6.

Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells.

Hapuarachchige S, Kato Y, Ngen EJ, Smith B, Delannoy M, Artemov D.

PLoS One. 2016 May 31;11(5):e0156294. doi: 10.1371/journal.pone.0156294. eCollection 2016.

7.

Lymphatic endothelial cells actively regulate prostate cancer cell invasion.

Shah T, Wildes F, Kakkad S, Artemov D, Bhujwalla ZM.

NMR Biomed. 2016 Jul;29(7):904-11. doi: 10.1002/nbm.3543. Epub 2016 May 5.

PMID:
27149683
8.

Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models.

Hapuarachchige S, Kato Y, Artemov D.

Sci Rep. 2016 Apr 12;6:24298. doi: 10.1038/srep24298.

9.

A preclinical murine model for the early detection of radiation-induced brain injury using magnetic resonance imaging and behavioral tests for learning and memory: with applications for the evaluation of possible stem cell imaging agents and therapies.

Ngen EJ, Wang L, Gandhi N, Kato Y, Armour M, Zhu W, Wong J, Gabrielson KL, Artemov D.

J Neurooncol. 2016 Jun;128(2):225-33. doi: 10.1007/s11060-016-2111-3. Epub 2016 Mar 28.

PMID:
27021492
10.

Association between breast cancer, breast density, and body adiposity evaluated by MRI.

Zhu W, Huang P, Macura KJ, Artemov D.

Eur Radiol. 2016 Jul;26(7):2308-16. doi: 10.1007/s00330-015-4058-8. Epub 2015 Oct 21.

11.

Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer.

Xu X, Chan KW, Knutsson L, Artemov D, Xu J, Liu G, Kato Y, Lal B, Laterra J, McMahon MT, van Zijl PC.

Magn Reson Med. 2015 Dec;74(6):1556-63. doi: 10.1002/mrm.25995. Epub 2015 Sep 25.

12.

Imaging transplanted stem cells in real time using an MRI dual-contrast method.

Ngen EJ, Wang L, Kato Y, Krishnamachary B, Zhu W, Gandhi N, Smith B, Armour M, Wong J, Gabrielson K, Artemov D.

Sci Rep. 2015 Sep 2;5:13628. doi: 10.1038/srep13628.

13.

HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.

Shah T, Krishnamachary B, Wildes F, Mironchik Y, Kakkad SM, Jacob D, Artemov D, Bhujwalla ZM.

Oncotarget. 2015 Sep 29;6(29):28104-19. doi: 10.18632/oncotarget.4612.

14.

Synthesis and Evaluation of Gd(III) -Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.

Banerjee SR, Ngen EJ, Rotz MW, Kakkad S, Lisok A, Pracitto R, Pullambhatla M, Chen Z, Shah T, Artemov D, Meade TJ, Bhujwalla ZM, Pomper MG.

Angew Chem Int Ed Engl. 2015 Sep 7;54(37):10778-82. doi: 10.1002/anie.201503417. Epub 2015 Jul 23.

15.

Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.

Kato Y, Zhu W, Backer MV, Neoh CC, Hapuarachchige S, Sarkar SK, Backer JM, Artemov D.

Pharm Res. 2015 Nov;32(11):3746-3755. doi: 10.1007/s11095-015-1736-9. Epub 2015 Jun 16.

16.

Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.

Penet MF, Shah T, Bharti S, Krishnamachary B, Artemov D, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZM.

Clin Cancer Res. 2015 Jan 15;21(2):386-95. doi: 10.1158/1078-0432.CCR-14-0964. Epub 2014 Nov 4.

17.

Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content.

Wabler M, Zhu W, Hedayati M, Attaluri A, Zhou H, Mihalic J, Geyh A, DeWeese TL, Ivkov R, Artemov D.

Int J Hyperthermia. 2014 May;30(3):192-200. doi: 10.3109/02656736.2014.913321.

18.

Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI.

Zhu W, Kato Y, Artemov D.

PLoS One. 2014 Jan 23;9(1):e86583. doi: 10.1371/journal.pone.0086583. eCollection 2014.

19.

Bioorthogonal, two-component delivery systems based on antibody and drug-loaded nanocarriers for enhanced internalization of nanotherapeutics.

Hapuarachchige S, Zhu W, Kato Y, Artemov D.

Biomaterials. 2014 Feb;35(7):2346-54. doi: 10.1016/j.biomaterials.2013.11.075. Epub 2013 Dec 15.

20.

Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid.

Zeng H, Xu J, Gillen J, McMahon MT, Artemov D, Tyburn JM, Lohman JA, Mewis RE, Atkinson KD, Green GG, Duckett SB, van Zijl PC.

J Magn Reson. 2013 Dec;237:73-8. doi: 10.1016/j.jmr.2013.09.012. Epub 2013 Sep 29.

21.

Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.

Zhu W, Kato Y, Artemov D.

MAGMA. 2014 Apr;27(2):161-70. doi: 10.1007/s10334-013-0389-0. Epub 2013 Jun 27.

22.

MR - eyes for cancer: looking within an impenetrable disease.

Penet MF, Artemov D, Farahani K, Bhujwalla ZM.

NMR Biomed. 2013 Jul;26(7):745-55. doi: 10.1002/nbm.2980. Review.

23.

Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.

Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J, Carrino JA, Cosgarea A, Artemov D, Chen Q, Zhao Z, Zhou X, Riley L, Sponseller P, Wan M, Lu WW, Cao X.

Nat Med. 2013 Jun;19(6):704-12. doi: 10.1038/nm.3143. Epub 2013 May 19.

24.

[Cellular factors of ischemia/reperfusion injury pathogenesis in the renal transplantation].

Vatazin AV, Astakhov PV, Zul'karnaev AB, Kantariia RO, Artemov DV.

Ross Fiziol Zh Im I M Sechenova. 2012 Jul;98(7):906-14. Review. Russian.

PMID:
23074839
25.

Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer.

Chan KW, McMahon MT, Kato Y, Liu G, Bulte JW, Bhujwalla ZM, Artemov D, van Zijl PC.

Magn Reson Med. 2012 Dec;68(6):1764-73. doi: 10.1002/mrm.24520. Epub 2012 Oct 16.

26.

Localized hypoxia results in spatially heterogeneous metabolic signatures in breast tumor models.

Jiang L, Greenwood TR, Artemov D, Raman V, Winnard PT Jr, Heeren RM, Bhujwalla ZM, Glunde K.

Neoplasia. 2012 Aug;14(8):732-41.

27.

Combined MR, fluorescence and histology imaging strategy in a human breast tumor xenograft model.

Jiang L, Greenwood TR, van Hove ER, Chughtai K, Raman V, Winnard PT Jr, Heeren RM, Artemov D, Glunde K.

NMR Biomed. 2013 Mar;26(3):285-98. doi: 10.1002/nbm.2846. Epub 2012 Sep 4.

28.

PSMA-targeted theranostic nanoplex for prostate cancer therapy.

Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT Jr, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM.

ACS Nano. 2012 Sep 25;6(9):7752-7762. doi: 10.1021/nn301725w. Epub 2012 Aug 9.

29.

Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.

Vesuna F, Lisok A, Kimble B, Domek J, Kato Y, van der Groep P, Artemov D, Kowalski J, Carraway H, van Diest P, Raman V.

Oncogene. 2012 Jul 5;31(27):3223-34. doi: 10.1038/onc.2011.483. Epub 2011 Nov 7.

30.

Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.

Shah T, Stasinopoulos I, Wildes F, Kakkad S, Artemov D, Bhujwalla ZM.

NMR Biomed. 2012 May;25(5):746-54. doi: 10.1002/nbm.1789. Epub 2011 Sep 22.

31.

Metabolic signatures imaged in cancer-induced cachexia.

Penet MF, Gadiya MM, Krishnamachary B, Nimmagadda S, Pomper MG, Artemov D, Bhujwalla ZM.

Cancer Res. 2011 Nov 15;71(22):6948-56. doi: 10.1158/0008-5472.CAN-11-1095. Epub 2011 Sep 26.

32.

Biocompatible blood pool MRI contrast agents based on hyaluronan.

Zhu W, Artemov D.

Contrast Media Mol Imaging. 2011 Mar-Apr;6(2):61-8. doi: 10.1002/cmmi.404. Epub 2010 Oct 28.

33.

Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.

Li C, Penet MF, Wildes F, Takagi T, Chen Z, Winnard PT, Artemov D, Bhujwalla ZM.

ACS Nano. 2010 Nov 23;4(11):6707-16. doi: 10.1021/nn102187v. Epub 2010 Oct 19.

34.

Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.

Shah T, Wildes F, Penet MF, Winnard PT Jr, Glunde K, Artemov D, Ackerstaff E, Gimi B, Kakkad S, Raman V, Bhujwalla ZM.

NMR Biomed. 2010 Jul;23(6):633-42. doi: 10.1002/nbm.1510.

35.

Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique.

Onuki Y, Jacobs I, Artemov D, Kato Y.

Biomaterials. 2010 Sep;31(27):7132-8. doi: 10.1016/j.biomaterials.2010.06.008. Epub 2010 Jun 26.

36.

Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Glunde K, Artemov D, Penet MF, Jacobs MA, Bhujwalla ZM.

Chem Rev. 2010 May 12;110(5):3043-59. doi: 10.1021/cr9004007. Review. No abstract available.

37.

Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.

Kato Y, Holm DA, Okollie B, Artemov D.

Neuro Oncol. 2010 Jan;12(1):71-9. doi: 10.1093/neuonc/nop006. Epub 2009 Oct 20.

38.

Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.

Penet MF, Pathak AP, Raman V, Ballesteros P, Artemov D, Bhujwalla ZM.

Cancer Res. 2009 Nov 15;69(22):8822-9. doi: 10.1158/0008-5472.CAN-09-1782. Epub 2009 Oct 27.

39.
40.

Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.

Mikhaylova M, Stasinopoulos I, Kato Y, Artemov D, Bhujwalla ZM.

Cancer Gene Ther. 2009 Mar;16(3):217-26. doi: 10.1038/cgt.2008.79. Epub 2008 Oct 17.

41.

Molecular and functional imaging of breast cancer.

Glunde K, Jacobs MA, Pathak AP, Artemov D, Bhujwalla ZM.

NMR Biomed. 2009 Jan;22(1):92-103. doi: 10.1002/nbm.1269. Review.

PMID:
18792419
42.

Conjugation of poly-L-lysine to bacterial cytosine deaminase improves the efficacy of enzyme/prodrug cancer therapy.

Li C, Wildes F, Winnard P Jr, Artemov D, Penet MF, Bhujwalla ZM.

J Med Chem. 2008 Jun 26;51(12):3572-82. doi: 10.1021/jm800288h. Epub 2008 Jun 3.

PMID:
18517259
43.

Receptor imaging of pediatric tumors: clinical practice and new developments.

Daldrup-Link HE, Hawkins RA, Meier R, Goldsby RE, Artemov D.

Pediatr Radiol. 2008 Nov;38(11):1154-61. doi: 10.1007/s00247-008-0878-x. Epub 2008 May 16. Review.

PMID:
18483730
44.

PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach.

Zhu W, Okollie B, Bhujwalla ZM, Artemov D.

Magn Reson Med. 2008 Apr;59(4):679-85. doi: 10.1002/mrm.21508.

45.

Image-guided enzyme/prodrug cancer therapy.

Li C, Penet MF, Winnard P Jr, Artemov D, Bhujwalla ZM.

Clin Cancer Res. 2008 Jan 15;14(2):515-22. doi: 10.1158/1078-0432.CCR-07-1837.

46.

Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.

Glunde K, Shah T, Winnard PT Jr, Raman V, Takagi T, Vesuna F, Artemov D, Bhujwalla ZM.

Cancer Res. 2008 Jan 1;68(1):172-80. doi: 10.1158/0008-5472.CAN-07-2678.

47.

Hypoxia and the presence of human vascular endothelial cells affect prostate cancer cell invasion and metabolism.

Ackerstaff E, Artemov D, Gillies RJ, Bhujwalla ZM.

Neoplasia. 2007 Dec;9(12):1138-51.

48.

Controlled internalization of Her-2/ neu receptors by cross-linking for targeted delivery.

Zhu W, Okollie B, Artemov D.

Cancer Biol Ther. 2007 Dec;6(12):1960-6. Epub 2007 Sep 4.

PMID:
18075296
49.

Development of novel chimeric transmembrane proteins for multimodality imaging of cancer cells.

Winnard PT Jr, Kluth JB, Kato Y, Artemov D, Raman V.

Cancer Biol Ther. 2007 Dec;6(12):1889-99. Epub 2007 Sep 1.

PMID:
18059163
50.

MRI of regular-shaped cell-encapsulating polyhedral microcontainers.

Gimi B, Artemov D, Leong T, Gracias DH, Bhujwalla ZM.

Magn Reson Med. 2007 Dec;58(6):1283-7.

Supplemental Content

Loading ...
Support Center